48.58 +0.00 (0.00%)
AMGN
Stock Details
Last Trade:48.58 Change:+0.00 (0.00%) Prev Close:48.58 Open: 48.25 Days Range:45.00 – 49.69 52 Week Range: 27.00 - 66.51 Volume:20168095 P/E: 17.05EPS:2.85
View AllRecent Alerts 10/13/08
Recent Alert on 10/08/08 at 10:52am
Pressure BioSciences (PBIO) Comments on Favorable Data Presented by Scientists at Amgen (AMGN)
Pressure BioSciences (PBIO) Comments on Favorable Data Presented by Scientists at Amgen (AMGN)
Pressure BioSciences, Inc. (Nasdaq: PBIO) ("PBI") provided an update on various corporate activities, including the presentation of favorable data generated by scientists at Amgen, Inc. (Nasdaq: AMGN) on the Company's pressure cycling technology... Read More
Recent Alert on 10/03/08 at 1:48pm
Amgen (AMGN) Appoints Francois de Carbonnel to the Company's Board
Amgen (AMGN) Appoints Francois de Carbonnel to the Company's Board
Recent Alert on 10/02/08 at 10:05am
Notable Analyst Rating Changes 10/2: DRIV, AMGN, BP Upgraded; LVS, AA, JAVA, JNPR Downgraded
Notable Analyst Rating Changes 10/2: DRIV, AMGN, BP Upgraded; LVS, AA, JAVA, JNPR Downgraded
Recent Alert on 09/22/08 at 8:03am
ARIAD Pharmaceuticals (ARIA) Announces Disappointing Ruling Regarding NF-(kappa)B Patent Lawsuit with Amgen (AMGN)
ARIAD Pharmaceuticals (ARIA) Announces Disappointing Ruling Regarding NF-(kappa)B Patent Lawsuit with Amgen (AMGN)
View AllRecent Press Releases
Press Release on 10/10/08 at 4:11pm
Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche
Amgen Issues Statement on Court of Appeals Ruling That Affirms Preliminary Injunction Against Roche
View AllRecent SEC Filings
No Recent SEC Filings Available
View AllRecent Blog Posts
Blog Posts on 10/02/08 at 8:16am
Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)
Top Pre-Market Analyst Upgrades (AMGN, CPLP, DRIV, DSX, DNA, GNK, MAKO)
Blog Posts on 09/14/08 at 10:32am
Interview with Jamia Jasper, American Israeli Shared Values Capital Appreciation Fund
Interview with Jamia Jasper, American Israeli Shared Values Capital Appreciation Fund

